指南与共识泌尿生殖与妇科肿瘤放疗放疗物理与技术

GYN GEC-ESTRO ACROP 建议:原发性阴道癌图像引导自适应近距离放疗靶区概念

Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.
指南 / 共识 · Radiother Oncol · 2019-12-23

该建议由 GYN GEC-ESTRO 工作组于 2013 年启动,基于共识流程提出原发性阴道癌图像引导自适应近距离放疗(IGABT)的靶区概念。靶区按治疗阶段和肿瘤反应划分:外照射(EBRT)针对原发肿瘤和淋巴结,IGABT 针对残留大体肿瘤体积(GTV-Tres)及高、中危临床靶体积(CTV-THR、CTV-TIR)。该概念旨在规范体积剂量处方并提高不同放疗方案的可比性。

要点

  • 妇科检查和 MR 成像是原发肿瘤局部评估的首选方法。
  • EBRT 靶区包括原发肿瘤和淋巴结,IGABT 靶区包括 GTV-Tres、CTV-THR 和 CTV-TIR。
  • 该共识靶区概念用于体积剂量处方,计划开展多中心前瞻性评估。

核心结论

  • 该建议提出了原发性阴道癌 IGABT 的自适应靶区概念,用于体积剂量处方并提高不同放疗方案的可比性。

主要发现

  • 妇科检查和 MR 成像是局部肿瘤评估的首选方式。
  • 开发了用于阴道癌标准化记录并附临床绘图的专用模板。
  • 自适应靶区概念包括不同反应相关靶区:EBRT 相关靶区涉及原发肿瘤和淋巴结,IGABT 相关靶区涉及原发肿瘤并由残留大体肿瘤体积(GTV-Tres)及高危、中危临床靶体积(CTV-THR、CTV-TIR)组成。

关键数值与推荐

  • IGABT 靶区包括残留大体肿瘤体积(GTV-Tres)以及高危临床靶体积(CTV-THR)和中危临床靶体积(CTV-TIR)。

临床怎么用

  • 在原发阴道癌的 EBRT 联合近距离放疗中,可按本共识采用妇科检查与 MR 成像评估,并基于自适应靶区概念进行 IGABT 的体积剂量处方。

局限性

  • 该靶区概念基于共识和回顾性分析,尚需多中心前瞻性研究评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: External beam radiotherapy (EBRT) combined with brachytherapy has an essential role in the curative treatment of primary vaginal cancer. EBRT is associated with significant tumour shrinkage, making primary vaginal cancer suitable for image guided adaptive brachytherapy (IGABT). The aim of these recommendations is to introduce an adaptive target volume concept for IGABT of primary vaginal cancer. METHODS: In December 2013, a task group was initiated within GYN GEC-ESTRO with the purpose to introduce an IGABT target concept for primary vaginal cancer. All participants have broad experience in IGABT and vaginal cancer brachytherapy. The target concept was elaborated as consensus agreement based on an iterative process including target delineation and dose planning comparison, retrospective analysis of clinical data and expert opinions. RESULTS: Gynaecological examination and MR imaging are the modalities of choice for local tumour assessment. A specific template for standardised documentation with clinical drawings for vaginal cancer was developed. The adaptive target volume concept comprises different response-related target volumes. For EBRT these are related to the primary tumour and the lymph nodes, while for IGABT these are related to the primary tumour and are consisting of the residual gross tumour volume (GTV-Tres) and the high-, and intermediate risk clinical target volumes (CTV-THR, CTV-TIR). CONCLUSION: This target concept for IGABT of primary vaginal cancer defines adaptive target volumes for volumetric dose prescription and should improve comparability of different radiotherapy schedules of this rare disease. A prospective evaluation of the target volume concept within a multicentre study is planned.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Schmid MP, Fokdal L, Westerveld H, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer. Radiother Oncol. 2019. PMID: 31874348. doi:10.1016/j.radonc.2019.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。